MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-13-2026
Inspire Medical Systems Total Assets 2011-2026 | INSP
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Inspire Medical Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 907 M | 808 M | 677 M | 565 M | 295 M | 281 M | 181 M | 200 M | 25.1 M | 13.1 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 907 M | 13.1 M | 395 M |
Quarterly Total Assets Inspire Medical Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 808 M | 802 M | 731 M | 808 M | 796 M | 728 M | 686 M | 677 M | 639 M | 618 M | 572 M | 565 M | 528 M | - | 290 M | 295 M | 279 M | 272 M | 273 M | 281 M | 281 M | 281 M | 281 M | 181 M | 181 M | 181 M | 181 M | 200 M | 200 M | 200 M | 200 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 808 M | 25.1 M | 386 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abbott Laboratories
ABT
|
86.7 B | $ 102.87 | 0.48 % | $ 179 B |  USA |
 |
Align Technology
ALGN
|
6.21 B | $ 170.6 | -1.23 % | $ 12.8 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 10.83 | -3.82 % | $ 1.63 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
222 M | $ 34.44 | 2.56 % | $ 1.59 B | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.37 | 2.52 % | $ 265 M | USA |
 |
Accuray Incorporated
ARAY
|
470 M | $ 0.42 | 6.82 % | $ 43.2 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.58 | 6.52 % | $ 36.1 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.63 | 0.94 % | $ 345 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 23.29 | -1.52 % | $ 197 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 36.76 | 1.88 % | $ 5.48 K | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 62.82 | 1.32 % | $ 93 B | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 81.05 | -0.26 % | $ 47.4 B | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 34.79 | -2.08 % | $ 1.08 B | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Aethlon Medical
AEMD
|
7.36 M | $ 2.12 | -1.4 % | $ 3.31 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.03 | 1.43 % | $ 1.63 B | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.86 | 9.41 % | $ 1.13 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.53 | -0.42 % | $ 734 M | USA |
 |
Inogen
INGN
|
299 M | $ 6.21 | -0.96 % | $ 165 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 16.06 | -1.41 % | $ 377 M | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 0.98 | 3.17 % | $ 16.6 M | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 86.85 | 0.47 % | $ 3.02 B | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 63.79 | -1.3 % | $ 3.48 B |  Britain |
 |
LENSAR
LNSR
|
71.4 M | $ 6.06 | 1.51 % | $ 72.5 M | USA |